EW

Edwards Lifesciences
D

EW

Arincen78/100B

Edwards Lifesciences operating income 1999–2026

Edwards Lifesciences's operating income in Q3 FY2026, the three months to 30 September 2026, was 299.10M USD, down 29.6% on the same quarter a year before. Edwards Lifesciences's operating income over the last twelve months was 1.66B USD, up 6.2% on the twelve months before. In fiscal year 2025 it was 1.64B USD, up 18.7% on the year before.

Last updated 10 Nov 2026 · Next report 9 Feb 2027

Operating income

Operating income · +11.0% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 20261.66B+6.19%24.87%5.22B78.13%1.60B
FY202531 Dec 20251.64B+18.68%26.97%4.74B78.13%1.43B
FY202431 Dec 20241.38B-3.41%25.35%4.32B79.46%1.72B
FY202331 Dec 20231.43B-16.16%28.49%3.97B79.30%1.53B
FY202231 Dec 20221.70B+5.71%31.63%4.22B78.31%1.93B
FY202131 Dec 20211.61B+24.26%30.78%4.01B76.57%1.86B
FY202031 Dec 20201.30B+8.19%29.55%3.29B74.94%1.05B
FY201931 Dec 20191.20B+9.67%27.55%3.19B73.43%1.28B
FY201831 Dec 20181.09B+8.14%29.34%2.80B75.23%872.20M
FY201731 Dec 20171.01B+23.86%29.40%2.55B74.30%1.14B
FY201631 Dec 2016815.50M+41.60%27.52%2.16B72.81%827.10M
FY201531 Dec 2015575.90M+18.21%23.09%1.81B72.56%706.60M
FY201431 Dec 2014487.20M+12.52%20.97%1.69B72.83%1.23B
FY201331 Dec 2013433.00M+9.15%21.17%1.50B73.41%589.80M
FY201231 Dec 2012396.70M+20.54%20.88%1.39B73.32%452.80M
FY201131 Dec 2011329.10M+16.50%19.61%1.22B72.55%344.70M
FY201031 Dec 2010282.50M+21.24%19.52%1.04B71.66%327.10M
FY200931 Dec 2009233.00M+11.48%17.63%917.30M69.42%365.80M
FY200831 Dec 2008209.00M+23.30%16.89%828.80M66.96%227.20M
FY200731 Dec 2007169.50M+3.67%15.53%709.80M65.05%213.70M
FY200631 Dec 2006163.50M-6.89%15.77%653.70M63.04%239.60M
FY200531 Dec 2005175.60M+13.73%17.60%623.30M62.46%185.20M
FY200431 Dec 2004154.40M+11.56%16.58%561.30M60.26%100.00M
FY200331 Dec 2003138.40M+165.64%16.08%501.10M58.23%184.00M
FY200231 Dec 200252.10M+117.08%7.40%404.90M57.51%92.50M
FY200131 Dec 200124.00M-74.74%3.47%368.00M53.18%81.10M
FY200031 Dec 200095.00M-18.80%11.82%381.00M47.39%169.00M
FY199931 Dec 1999117.00M—12.93%439.00M48.51%201.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Edwards Lifesciences's operating income

Source: Financial Modeling Prep